Arrowhead Research reported $-85511000 in Net Income for its third fiscal quarter of 2022.


Ok
Trading Economics members can view, download and compare data from nearly 200 countries, including more than 20 million economic indicators, exchange rates, government bond yields, stock indexes and commodity prices.

The Trading Economics Application Programming Interface (API) provides direct access to our data. It allows API clients to download millions of rows of historical data, to query our real-time economic calendar, subscribe to updates and receive quotes for currencies, commodities, stocks and bonds.

Please Paste this Code in your Website
width
height
Net Income Change
Agios Pharmaceuticals AGIO:US USD -81747000 10.06M
Alnylam Pharmaceuticals ALNY:US USD -405920000 128.52M
Arrowhead Research ARWR:US USD -85511000 13.46M
Bluebird Bio BLUE:US USD -76520000 23.62M
Intercept Pharmaceuticals ICPT:US USD 267.45M 274.98M
IONIS PHARMACEUT IONS:US USD -46992000 58.14M
Merk MRK:US USD 3.25B 696M
Mirati Therapeutics MRTX:US USD -173561000 2.88M
Moderna Inc MRNA:US USD 1.04B 1.15B
Nektar Therapeutics NKTR:US USD -59049000 100.02M
Novartis NOVN:VX USD 1.57B 121M
Sarepta Therapeutics SRPT:US USD -257738000 26.26M
Tg Therapeutics TGTX:US USD -35818000 4.69M
Ultragenyx Pharmaceutical RARE:US USD -245106000 86.94M
Vertex Pharmaceuticals VRTX:US USD 930.5M 120M
Xencor XNCR:US USD -32759000 1.22M
YTE INCY:US USD 112.78M 48.66M